Boston Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Boston Scientific Corp
BSX Stock  USD 74.58  1.14  1.51%   
Boston Scientific's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Boston Scientific's valuation are provided below:
Gross Profit
13.8 B
Profit Margin
0.1444
Market Capitalization
112.3 B
Enterprise Value Revenue
6.0574
Revenue
20.1 B
We have found one hundred twenty available fundamental signals for Boston Scientific Corp, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Boston Scientific Corp prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 124.2 B in 2026. Enterprise Value is likely to rise to about 64.2 B in 2026

Boston Scientific Total Revenue

21.08 Billion

Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 B, Interest Expense of 225.5 M or Selling General Administrative of 7.2 B, as well as many indicators such as Price To Sales Ratio of 4.79, Dividend Yield of 4.0E-4 or PTB Ratio of 5.91. Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.
  
Build AI portfolio with Boston Stock
Check out the analysis of Boston Scientific Correlation against competitors.

Boston Scientific Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets45.9 B43.7 B25.8 B
Slightly volatile
Short and Long Term Debt Total13 B12.4 B7.4 B
Slightly volatile
Other Current Liabilities1.8 B3.3 B2.3 B
Slightly volatile
Total Current Liabilities5.7 B5.4 B3.7 B
Slightly volatile
Total Stockholder Equity25.4 B24.2 B12.6 B
Slightly volatile
Property Plant And Equipment Net4.7 B4.5 B2.3 B
Slightly volatile
Net Debt10.9 B10.4 B6.6 B
Slightly volatile
Accounts Payable1.2 B1.1 B555.5 M
Slightly volatile
Cash2.1 B2 B729.9 M
Slightly volatile
Non Current Assets Total36.6 B34.9 B21 B
Slightly volatile
Non Currrent Assets Other587 M559 M547.3 M
Slightly volatile
Cash And Short Term Investments2.1 B2 B729.9 M
Slightly volatile
Net Receivables3.1 B2.9 B1.7 B
Slightly volatile
Common Stock Shares Outstanding1.2 B1.5 B1.3 B
Slightly volatile
Liabilities And Stockholders Equity45.9 B43.7 B25.8 B
Slightly volatile
Non Current Liabilities Total14.5 B13.8 B9.4 B
Slightly volatile
Inventory3.1 B2.9 B1.5 B
Slightly volatile
Other Current Assets797.7 M879 M903.7 M
Slightly volatile
Other Stockholder Equity10.6 B19.3 B15.2 B
Slightly volatile
Total Liabilities20.2 B19.2 B13.1 B
Slightly volatile
Property Plant And Equipment Gross8.8 B8.4 B3.2 B
Slightly volatile
Total Current Assets9.2 B8.8 B4.8 B
Slightly volatile
Short Term Debt461.7 M389 M553.4 M
Slightly volatile
Intangible Assets4.6 B7 B5.8 B
Slightly volatile
Common Stock Total Equity14.1 M19.6 M15.6 M
Slightly volatile
Common Stock14.7 M19.6 M15.8 M
Slightly volatile
Other Liabilities1.9 B2.1 B2.2 B
Very volatile
Long Term Debt6 B11.1 B6.3 B
Slightly volatile
Good Will9.4 B18.3 B9.4 B
Slightly volatile
Property Plant Equipment4.7 B4.5 B2.3 B
Slightly volatile
Current Deferred Revenue326.3 M313 M297.5 M
Slightly volatile
Long Term Debt Total7.4 B11.1 B6.7 B
Slightly volatile
Capital Surpluse20 B21.5 B18.3 B
Slightly volatile
Non Current Liabilities Other542.1 M570.6 M1.9 B
Slightly volatile
Long Term Investments473.9 M638.2 M344.4 M
Slightly volatile
Short and Long Term Debt2.1 B2 B843.9 M
Slightly volatile
Cash And Equivalents2.1 B2 B695.1 M
Slightly volatile
Capital Lease Obligations325.3 M606 M194.4 M
Slightly volatile
Net Invested Capital26.1 B37.2 B20.1 B
Slightly volatile
Capital Stock18.4 M19.6 M16.6 M
Slightly volatile

Boston Scientific Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.5 B1.5 B938.7 M
Slightly volatile
Selling General Administrative7.2 B6.9 B3.8 B
Slightly volatile
Total Revenue21.1 B20.1 B10.7 B
Slightly volatile
Gross Profit14.5 B13.9 B6.8 B
Slightly volatile
Other Operating Expenses16.9 B16.1 B9 B
Slightly volatile
Operating Income4.2 B4 B1.7 B
Slightly volatile
Cost Of Revenue6.5 B6.2 B3.9 B
Slightly volatile
Total Operating Expenses10.4 B9.9 B5.2 B
Slightly volatile
Research Development2.2 B2.1 B1.1 B
Slightly volatile
Selling And Marketing Expenses180.8 M203.4 M222 M
Slightly volatile
Non Recurring321.5 M338.4 M875.6 M
Slightly volatile
Interest Income200.2 M349 M220.4 M
Pretty Stable
Reconciled Depreciation1.1 B1.5 B959.4 M
Slightly volatile

Boston Scientific Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow667 M606 M724.6 M
Slightly volatile
Depreciation1.4 B1.4 B927.8 M
Slightly volatile
Capital Expenditures919.8 M876 M452.2 M
Slightly volatile
Total Cash From Operating Activities4.8 B4.5 B1.8 B
Slightly volatile
End Period Cash Flow2.3 B2.1 B914.3 M
Slightly volatile
Stock Based Compensation225.3 M299 M160.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.797.03184.485
Slightly volatile
Dividend Yield4.0E-44.0E-40.0011
Slightly volatile
PTB Ratio5.915.8254.7641
Very volatile
Days Sales Outstanding67.1353.202760.3806
Slightly volatile
Book Value Per Share17.3616.53078.8758
Slightly volatile
Operating Cash Flow Per Share3.223.06271.232
Slightly volatile
Stock Based Compensation To Revenue0.01730.01490.0154
Slightly volatile
Capex To Depreciation0.610.64040.5592
Pretty Stable
PB Ratio5.915.8254.7641
Very volatile
EV To Sales3.857.54854.9974
Slightly volatile
ROIC0.10.08780.0737
Pretty Stable
Inventory Turnover2.252.11312.6975
Slightly volatile
Days Of Inventory On Hand155173138
Slightly volatile
Payables Turnover5.175.43798.5028
Slightly volatile
Sales General And Administrative To Revenue0.40.390.3438
Slightly volatile
Research And Ddevelopement To Revenue0.130.10220.1085
Very volatile
Capex To Revenue0.08290.04360.0425
Slightly volatile
Cash Per Share1.451.38140.5095
Slightly volatile
POCF Ratio47.5431.132837.9163
Pretty Stable
Interest Coverage7.0611.37826.5766
Pretty Stable
Capex To Operating Cash Flow0.180.19320.313
Very volatile
Days Payables Outstanding35.6767.12145.9488
Slightly volatile
EV To Operating Cash Flow52.033.420643.1087
Pretty Stable
Intangibles To Total Assets0.410.57940.5941
Very volatile
Current Ratio1.91.61681.5062
Slightly volatile
Receivables Turnover4.856.86066.0426
Slightly volatile
Graham Number28.1426.795612.4093
Slightly volatile
Shareholders Equity Per Share17.1916.36928.837
Slightly volatile
Debt To Equity0.460.51240.6056
Very volatile
Capex Per Share0.620.59170.3175
Slightly volatile
Revenue Per Share14.2413.55987.5382
Slightly volatile
Interest Debt Per Share9.068.6245.4103
Slightly volatile
Debt To Assets0.210.28430.2738
Slightly volatile
Short Term Coverage Ratios11.0711.655573.2671
Slightly volatile
Operating Cycle222226198
Slightly volatile
Price Book Value Ratio5.915.8254.7641
Very volatile
Days Of Payables Outstanding35.6767.12145.9488
Slightly volatile
Price To Operating Cash Flows Ratio47.5431.132837.9163
Pretty Stable
Operating Profit Margin0.20.19780.1565
Very volatile
Company Equity Multiplier1.661.80222.1578
Slightly volatile
Long Term Debt To Capitalization0.230.3210.3418
Pretty Stable
Total Debt To Capitalization0.270.33880.368
Very volatile
Return On Capital Employed0.180.10390.111
Slightly volatile
Debt Equity Ratio0.460.51240.6056
Very volatile
Ebit Per Revenue0.20.19780.1565
Very volatile
Quick Ratio1.41.07561.0373
Slightly volatile
Dividend Paid And Capex Coverage Ratio2.815.17583.5975
Pretty Stable
Net Income Per E B T0.70.85261.1359
Very volatile
Cash Ratio0.390.3760.1963
Slightly volatile
Cash Conversion Cycle173159151
Pretty Stable
Operating Cash Flow Sales Ratio0.120.22590.1454
Slightly volatile
Days Of Inventory Outstanding155173138
Slightly volatile
Days Of Sales Outstanding67.1353.202760.3806
Slightly volatile
Cash Flow Coverage Ratios0.50.36510.2929
Pretty Stable
Price To Book Ratio5.915.8254.7641
Very volatile
Fixed Asset Turnover5.284.45994.8517
Slightly volatile
Capital Expenditure Coverage Ratio2.95.17583.6554
Pretty Stable
Price Cash Flow Ratio47.5431.132837.9163
Pretty Stable
Debt Ratio0.210.28430.2738
Slightly volatile
Cash Flow To Debt Ratio0.50.36510.2929
Pretty Stable
Price Sales Ratio4.797.03184.485
Slightly volatile
Asset Turnover0.660.45960.5013
Slightly volatile
Gross Profit Margin0.730.69010.6357
Pretty Stable
Price Fair Value5.915.8254.7641
Very volatile

Boston Scientific Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap124.2 B118.3 B57.2 B
Slightly volatile
Enterprise Value64.2 B61.2 B49 B
Slightly volatile

Boston Fundamental Market Drivers

Forward Price Earnings21.5517
Cash And Short Term Investments2 B

Boston Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Boston Scientific Financial Statements

Boston Scientific investors use historical fundamental indicators, such as Boston Scientific's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Boston Scientific. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue313 M326.3 M
Total Revenue20.1 B21.1 B
Cost Of Revenue6.2 B6.5 B
Stock Based Compensation To Revenue 0.01  0.02 
Sales General And Administrative To Revenue 0.39  0.40 
Research And Ddevelopement To Revenue 0.10  0.13 
Capex To Revenue 0.04  0.08 
Revenue Per Share 13.56  14.24 
Ebit Per Revenue 0.20  0.20 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY